Certified by Founder Lodge
Capstan Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $175,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Capstan is a biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The core platform technology comprise
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 21 ,2024 | Series B | $175,000,000 |
Mubadala Capital
Eli Lilly and Company
Polaris Partners
Alexandria Real Estate Equities, Inc.
Pfizer
RA Capital Management, L.P.
Novartis
Perceptive Advisors
Vida Ventures, LLC
Bristol Myers Squibb
Forbion
Sofinnova Investments
Leaps by Bayer
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
